Treat an autism test as a decision point
Autism screening is a brief, standardized way to estimate whether your child may be at risk; it is not a diagnosis. Screening tools are used before an in-depth diagnostic evaluation to identify children who may need a closer look. A positive result gives you a reason to discuss next steps, not a final answer about your child. Do not treat a screening result as proof that your child is or is not autistic.
A diagnostic evaluation combines your description of your child’s development with a professional’s observation and standardized diagnostic criteria. The American Academy of Pediatrics recommends autism screening at 18 months and 24 months, alongside developmental surveillance. Autism screening often begins at a routine well-check, but you can raise a concern with your child’s clinician at any time.
U.S. cost estimates list formal autism screening at $1,000 to $5,000 and informal screening at $0 to $500; those labels do not tell you whether a service provides a diagnosis. Costs vary by evaluation type, so keep screening and diagnostic evaluation separate when you compare services. Timing also varies by setting. In one Early Autism Evaluation Hub system, clinicians evaluated 2,076 children ages 18 to 48 months from 2012 to 2018; the median evaluation wait was 62 days, and 33% received an autism diagnosis. That example describes one system, not a wait time or result you should expect in San Jose.
Your practical question is therefore not simply whether a questionnaire is positive. Use this sequence:
- If your child is at a recommended screening visit, ask which developmental or autism screen is being used.
- If you have a concern now, describe the behavior or developmental change instead of waiting for a scheduled screen.
- If screening suggests increased likelihood, ask a qualified clinician about a diagnostic evaluation.
- If concern continues despite a non-positive score, request professional follow-up anyway.
This keeps the questionnaire in its proper role: a way to guide the next conversation.
Locate screening in the child’s care timeline
Developmental screening fits into regular health care as well as concern-driven follow-up. The American Academy of Pediatrics recommends general developmental screening at 9 months, 18 months, and 30 months, and screening whenever you or a clinician raises a concern. Autism screening often begins at a routine well-check, where you can describe what you have noticed.
Developmental surveillance means ongoing attention to your child’s development, your concerns, and informal observations during routine care. Surveillance is useful, but surveillance alone may not identify every child who needs an autism evaluation because a brief office visit may not show every relevant behavior. Share concerns even when a scheduled screen has not yet occurred. A clinician can then decide whether screening, broader developmental assessment, or a more in-depth evaluation fits the concern.
Guidance differs on universal autism screening. The Centers for Disease Control and Prevention and the American Academy of Pediatrics recommend autism-specific screening at 18 and 24 months alongside developmental surveillance and broader developmental screening. The United States Preventive Services Task Force says current evidence is insufficient to assess the benefits and harms of screening young children when neither you nor a clinician has raised an autism concern. When concerns exist, discuss screening or evaluation with your child’s clinician rather than waiting for a particular appointment.
Your concern is a valid reason to start the discussion outside the usual schedule. Write down what you notice, when it began, and where it happens—such as at home, in child care, or during play—then bring those examples to the pediatrician or another qualified clinician. Developmental screening is recommended when a concern arises, not only at a specific age.
Read a screening pathway without overreading it
Common developmental or autism screening tools include the Ages and Stages questionnaire, Parents’ Evaluation of Developmental Status, and the Modified Checklist for Autism in Toddlers, usually called the M-CHAT. The M-CHAT is a parent questionnaire that helps identify children who may be at risk for autism. Its questions address behaviors that may indicate autism, but the questionnaire casts a broad net and can flag children who may or may not be autistic.
The M-CHAT-R score is a risk signal that determines follow-up; it is not an autism diagnosis. Use the score as a prompt to speak with a clinician, not as a conclusion about your child. A screening result can also point toward other developmental concerns, so a positive result deserves attention even when autism is not ultimately diagnosed.
The M-CHAT-R pathway uses these score ranges:
- Total score 0–2: This range indicates low likelihood. If your child is younger than 24 months, repeat the screen after the second birthday when developmental surveillance still indicates concern.
- Total score 3–7: This range indicates moderate likelihood. Complete the Follow-Up interview. If two or more items remain elevated, seek referrals for early intervention and a diagnostic evaluation.
- Total score 8–20: This range indicates high likelihood and a positive screen. Seek immediate referrals for early intervention and diagnostic evaluation; the Follow-Up is not needed first.
Follow the instructions for the version of the questionnaire used by your clinician. Do not calculate or interpret a score as a substitute for professional follow-up.
M-CHAT-R response scoring is not intuitive for every item. A “NO” indicates elevated likelihood for every item except items 2, 5, and 12, where “YES” indicates elevated likelihood. Use the scoring instructions for the version provided to you rather than treating an individual answer as a diagnosis.
A high-likelihood screening result does not guarantee an autism diagnosis. Other developmental disorders or delays may also be involved, and a positive result still needs a fuller evaluation. If you or a clinician remain concerned, request an evaluation even if the screening score is not positive.
Build a useful account of the child’s development
A professional evaluation may assess social communication, play, and restricted or repetitive behaviors through standardized activities and observation. During an ADOS-2 assessment, a specialist interacts directly with your child through social and play activities. The evaluator also combines those observations with your account of development rather than relying on one brief behavior or one questionnaire.
The evaluator may ask about developmental and family history, speak with teachers or previous treatment providers, and observe how your child communicates, plays, and responds during standardized activities. A caregiver interview and direct observation answer different parts of the assessment question.
Your preparation can make the developmental history more complete. Bring or write down:
- Information about your child’s birth and medical history, including medications and surgeries.
- Relevant pregnancy history and family history of neurological, developmental, mental-health, or birth-defect conditions.
- Screening results, developmental records, and specific examples from home, school, or child care.
- Contact information for teachers or previous treatment providers who may have useful observations.
The evaluator may speak with teachers, previous providers, or other caregivers as part of the history.
To make those notes easier to use, separate direct observations from your interpretation. Record what your child did or communicated, when you noticed it, and the setting in which it occurred; include meaningful changes over time. These concrete details give the evaluator developmental history to consider alongside screening responses without requiring you to decide what the behavior means.
A qualified evaluation should consider possible alternative explanations and co-occurring conditions because language disorders, ADHD, and other conditions can resemble or accompany autism. Autism can sometimes be detected at 18 months or younger, and by age 2 years an experienced professional’s diagnosis can be considered very reliable. A separate statewide report found that the average age of diagnosis was 4 to 5 years. That population-level figure does not determine when your child should be evaluated; your child’s concerns and developmental history should guide the conversation.
That broader review helps separate two questions: whether the child meets autism criteria and whether another developmental, sensory, behavioral, or medical concern also needs attention. The clinician may consider anxiety, global developmental delay, ADHD, vision impairment, or hearing impairment in addition to language delays. Mention any known concerns so the evaluator has relevant context rather than relying on the screening score alone. The presence of one of these concerns does not by itself answer the autism question; it explains why a fuller clinical picture matters.
Use population numbers for context, not prediction
Autism is a common neurodevelopmental condition that can affect how your child learns, communicates, and experiences the world. According to the cited Centers for Disease Control and Prevention estimate, 1 in 31 children aged 8 or older, or about 3%, had been diagnosed with autism. That figure describes a U.S. population estimate for children aged 8 or older; it does not predict your child’s result.
California’s 2022 surveillance data reported ASD prevalence of 60.6 per 1,000 children aged 4 years, based on 905 cases among 14,936 children. This California figure covers a specific age group and surveillance population. It offers context for a San Jose conversation, but it cannot tell you whether your child is autistic.
Autism characteristics can show up in some children during the first 12 months, while traits may not be apparent in others until age 2 or 3. Some autistic children meet developmental milestones until about 18 to 24 months and then stop learning new skills or lose skills they once had; this is sometimes called regression. If you notice a change or loss of skills, describe the timing and examples to your child’s clinician instead of trying to match the pattern to a population statistic.
Population numbers can answer how common a condition is across a defined group, but they cannot screen your child or replace an evaluation. Use them to understand why autism assessment is a common developmental-care question, then return to the observations, screening information, and professional guidance specific to your child.
The two figures also use different age groups and surveillance contexts, so they should not be compared as if they were the same measure. The U.S. estimate for children aged 8 or older and the California estimate for 4-year-olds provide background, not a calculation of an individual child’s likelihood. A child’s age, location, or a population percentage cannot replace direct discussion of observed development.
Plan for a variable evaluation price
U.S. autism evaluation costs typically range from a few hundred dollars to several thousand, depending on the evaluation type. Provider, location, insurance coverage, and how comprehensive the evaluation is can also change the amount. Use the following figures as broad U.S. reference ranges, not as a San Jose quote.
The U.S. cost estimates distinguish several types of assessment:
| Evaluation type | Cited estimate | What the estimate describes |
|---|---|---|
| Informal screening | $0–$500 | A basic or quick check for autism signs |
| Developmental evaluation | $250–$1,500 | An assessment of overall developmental skills |
| Diagnostic evaluation | $250–$2,500 | An evaluation described as determining whether a child meets autism spectrum disorder criteria |
| Comprehensive evaluation | $500–$3,000 | A broad assessment of strengths and challenges |
| Formal diagnostic tests | Up to $5,000 | Intensive assessments used for various diagnostic criteria |
The category matters because a low-cost screening and a comprehensive diagnostic evaluation do different jobs.
Before you schedule, ask for the quoted evaluation type, what the fee includes, whether follow-up is part of the quoted service, and how insurance affects your share. Ask the insurance plan and the provider separately because coverage and requirements can differ. Keep the price question connected to scope: a cheaper screening should not be treated as an equivalent substitute for a diagnostic evaluation.
A useful cost conversation has four parts:
- Type: Is the appointment an informal screen, developmental evaluation, diagnostic evaluation, or comprehensive evaluation?
- Scope: Does the fee include caregiver interviews, standardized activities, observation, a written report, or follow-up?
- Coverage: Does your plan cover this type of evaluation, and does it require a referral or particular network?
- Location and provider: Could the price change because of where the evaluation occurs or who provides it?
These questions help you compare like with like. They do not turn a general U.S. estimate into an individualized price.
Make a San Jose assessment contact plan
In San Jose, ask your child’s pediatrician or primary-care clinician about developmental screening. A referral from a primary-care physician may be necessary to access our assessment services, depending on your insurance plan. Do not assume that the same referral rule applies to every plan or provider.
Use the same questions when you contact an assessment service:
- Who conducts the evaluation, and what training or qualifications apply to the evaluation?
- Does the service provide screening, diagnostic evaluation, or both?
- Does the service include caregiver interviews, standardized tests, and direct observation?
- Does your insurance plan require a primary-care referral or use a particular network?
- What records, school information, or caregiver observations should you send before the appointment?
- How will the clinician explain the result and possible next steps?
These questions help you compare the scope of an assessment without assuming that any single service is appropriate for every child.
Before choosing a service, match its stated scope to the question you need answered. Ask whether the evaluator will gather your description of development, observe your child’s behavior, and explain the result and possible next steps. Those questions help you see whether the conversation will address both the history you provide and the professional observation used in diagnosis. If any part is unclear, ask the service to clarify it before scheduling; you do not need to predict the outcome to compare what the appointment covers.
Our autism evaluations are conducted by qualified experts and include interviews, standardized tests, and observational reviews. If you contact us, a primary-care referral may be necessary depending on your insurance plan. Ask about the referral requirement and the scope of the evaluation when you begin the conversation.
A clear first call can follow this order:
- Describe the developmental or behavioral concern and your child’s age.
- Ask whether the service offers screening, diagnostic evaluation, or both.
- Ask whether a primary-care referral is required under your insurance plan.
- Ask what the evaluation includes and what records to bring.
- Request the applicable cost information from the provider and your plan.
Then compare the answers with the questions above. The goal is to understand the service’s scope and requirements before choosing your next contact.
Before the call, review your specific policy for limitations or exclusions affecting autism-assessment coverage. Keep the assessment report, invoices, and referral letters together if you later navigate a claim. Ask the provider and the plan the same coverage question separately, and write down each answer; this keeps the service’s scope, the plan’s requirements, and any referral process from being treated as the same issue.

Request qualified evaluation when concern remains
A positive screen is a reason to request a more in-depth diagnostic evaluation. After a positive M-CHAT-R/F screen, seek an early-intervention referral and diagnostic testing as soon as possible. The screen identifies a need for follow-up; it does not settle the diagnosis.
Your continuing concern also matters. If you or a healthcare clinician remain concerned about autism, request an evaluation regardless of the M-CHAT-R or M-CHAT-R/F score. A negative Follow-Up score of 0–1 does not end the conversation when developmental surveillance still indicates elevated likelihood.
Your next action can be simple: save the screening result, write down the behaviors or developmental changes that prompted concern, and contact your child’s pediatrician or another qualified clinician. Do not wait for a particular score before raising a concern that remains present.
Do not use an online questionnaire score as a diagnosis, and do not use a single observed behavior to settle the question. A diagnostic evaluation depends on developmental history, professional observation, and standardized diagnostic criteria. Bring the information you have and let a qualified clinician determine what assessment is appropriate.
Choose the next conversation
Your next conversation should connect three pieces: what you have observed, what any screening result actually measures, and what type of evaluation may answer the remaining question. Bring your notes and records to your child’s pediatrician or a qualified assessment service in San Jose, then ask what follow-up is appropriate.
A screening score can help you start that conversation, but it should not replace it. If concern persists, request qualified follow-up even when the score is not positive. That gives you a supported next step without asking a questionnaire to answer a diagnostic question it was not designed to answer.
